Global Health Progress

Malaria kills one million people a year, most of them children in Africa’s so-called Malaria Belt (the sub-Saharan region). In partnership with the Gates Foundation, pharmaceuticals giant GlaxoSmithKline is preparing an ambitious clinical trial there, which promises to vaccinate 16,000 African children in seven countries with an experimental treatment. The challenge: How do you build a clinical infrastructure that can transmit x-rays and data into GSK’s network in places that have no electricity and no phones?

Read this story from Fast Company>>